Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
New painkiller GRT7041 enters first human safety tests
Symptom relief Recruiting nowThis early-stage study tests a new drug called GRT7041 in 70 healthy volunteers to see if it is safe and how the body processes it. The trial has two parts: some participants get a single dose, others get multiple doses over up to 14 days. The goal is to find the right dose and c…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC
-
Healthy men needed to track how new drug GRT6019 exits the body
Knowledge-focused Recruiting nowThis study looks at how a single dose of the experimental drug GRT6019 is processed and removed from the body. Ten healthy men aged 30 to 65 will take one dose and provide urine and stool samples. The goal is to understand the drug's breakdown products and how much is excreted, n…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC